JPML Declines MDL for Samsung Galaxy Smartphone Lawsuits

The U.S. Judicial Panel on Multidistrict Litigation (JPML) has denied a request to consolidate all lawsuits over the Samsung Galaxy Note 7 recall before one judge for coordinated pretrial proceedings.

Following reports of nearly 100 Samsung Galaxy Note 7 smartphone lithium ion batteries overheating, including at lest two dozen reports of burn injuries and other reports involving property damage, the electronics manufacturer issued a massive recall last year impacting nearly 2.5 million devices.

A number of product liability lawsuits and class action claims have been filed, alleging that Samsung sold a defectively designed and manufactured product.

Hair-Dye-Cancer-Lawsuits
Hair-Dye-Cancer-Lawsuits

A group of plaintiffs filed a motion to transfer all cases to a single judge as part of a federal MDL, or multidistrict litigation, which is designed to reduce duplicative discovery into common issues, avoid conflicting pretrial rulings and to serve the convenience of the parties, witnesses and the courts.

Following a hearing last month, the U.S. JPML issued an order denying transfer (PDF) on April 5, indicating that there are currently too few cases filed, and differences in the cases that do not warrant consolidation.

“At oral argument, all counsel stated that they were amenable to coordinating discovery to eliminate duplicative depositions and document productions,” the JPML noted. “In these circumstances, alternatives to centralization, such as informal cooperation among the relatively few involved attorneys and coordination among the involved courts, are eminently feasible and will be sufficient to minimize any potential for duplicative discovery or inconsistent pretrial rulings.”

In December, Samsung noted that about 93% of the smartphones sold to consumers had been returned. It then sent out a software update that was designed to disable the remaining devices, which will prevent them from being recharged and eliminated their ability to work as a mobile device.

Image Credit: Image via <a href="http://www.shutterstock.com/gallery-2974603p1.html?cr=00&pl=edit-00">Photomans</a> / <a href="http://www.shutterstock.com/editorial?cr=00&pl=edit-00">Shutterstock.com</a>



0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

In the six months since a Bard hernia mesh settlement agreement was reached, at least two dozen new lawsuits have been brought, as the implants continue to fail and require revision surgery.
As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025.
Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case.